Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma C Morris

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Current Opinion in Pharmacology|September 7, 2015
Cancer gene therapy with T cell receptors and chimeric antigen receptorsHans J Stauss, Emma C Morris, Hinrich Abken
Cytotherapy|January 19, 2019
T-cell receptor gene-modified cells: past promises, present methodologies and future challengesRita Tendeiro Rego, Emma C Morris, Mark W Lowdell
Immunotherapy Advances|April 3, 2026
Chimeric CD3ζ chains containing CD28 signalling motifs enhance antigen-specific IL-2 production and expansion of human TCR-engineered T cells <i>in vitro</i>Samuel J Burgess, Hans J Stauss, Emma C Morris
Nature Reviews. Immunology|May 18, 2021
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapyEmma C Morris, Sattva S Neelapu, Theodoros Giavridis, et al.
The Journal of Gene Medicine|May 22, 2012
Challenges in T cell receptor gene therapyBenjamin J Uttenthal, Ignatius Chua, Emma C Morris, et al.
Transplantation|June 5, 2003
Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support deviceSambit Sen, Rajiv Jalan, Emma C Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2005
A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protectionEmma C Morris, Aristotle Tsallios, Gavin M Bendle, et al.
Frontiers in Immunology|June 14, 2024
Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell functionAbdullah Degirmencay, Sharyn Thomas, Angelika Holler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adultsJonathan I Sive, Kirsty J Thomson, Emma C Morris, et al.
British Journal of Haematology|December 17, 2011
Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failureSajir G Mohamedbhai, Noha Edwards, Emma C Morris, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Current Opinion in Pharmacology|September 7, 2015
Cancer gene therapy with T cell receptors and chimeric antigen receptorsHans J Stauss, Emma C Morris, Hinrich Abken
Cytotherapy|January 19, 2019
T-cell receptor gene-modified cells: past promises, present methodologies and future challengesRita Tendeiro Rego, Emma C Morris, Mark W Lowdell
Immunotherapy Advances|April 3, 2026
Chimeric CD3ζ chains containing CD28 signalling motifs enhance antigen-specific IL-2 production and expansion of human TCR-engineered T cells <i>in vitro</i>Samuel J Burgess, Hans J Stauss, Emma C Morris
Nature Reviews. Immunology|May 18, 2021
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapyEmma C Morris, Sattva S Neelapu, Theodoros Giavridis, et al.
The Journal of Gene Medicine|May 22, 2012
Challenges in T cell receptor gene therapyBenjamin J Uttenthal, Ignatius Chua, Emma C Morris, et al.
Transplantation|June 5, 2003
Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support deviceSambit Sen, Rajiv Jalan, Emma C Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2005
A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protectionEmma C Morris, Aristotle Tsallios, Gavin M Bendle, et al.
Frontiers in Immunology|June 14, 2024
Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell functionAbdullah Degirmencay, Sharyn Thomas, Angelika Holler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adultsJonathan I Sive, Kirsty J Thomson, Emma C Morris, et al.
British Journal of Haematology|December 17, 2011
Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failureSajir G Mohamedbhai, Noha Edwards, Emma C Morris, et al.
Pageof 8